141 related articles for article (PubMed ID: 2443410)
1. Subcutaneous administration of the synthetic trypsin inhibitor Foy-305 induces hypertrophy of the exocrine pancreas.
Wereszczyńska-Siemiatkowska U; Pohl U; Otto J; Lankisch PG
Digestion; 1987; 37(3):144-8. PubMed ID: 2443410
[TBL] [Abstract][Full Text] [Related]
2. Effect of a specific serine protease inhibitor on the rat pancreas: systemic administration of camostate and exocrine pancreatic secretion.
Göke B; Stöckmann F; Müller R; Lankisch PG; Creutzfeldt W
Digestion; 1984; 30(3):171-8. PubMed ID: 6209186
[TBL] [Abstract][Full Text] [Related]
3. Effect of camostate administration for two weeks on experimental pancreatitis in mice and rats.
Leonhardt U; Seidensticker F; Stöckmann F; Creutzfeldt W
Pancreas; 1993 Jan; 8(1):98-102. PubMed ID: 7678329
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.
Niederau C; Liddle RA; Williams JA; Grendell JH
Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964
[TBL] [Abstract][Full Text] [Related]
5. Secretory responses of hypertrophied rat pancreas induced by repeated oral administrations of a synthetic protease inhibitor.
Yonezawa H
Jpn J Physiol; 1983; 33(2):183-95. PubMed ID: 6876500
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of the growth of azaserine-induced nodules in the rat pancreas by dietary camostate (FOY-305).
Lhoste EF; Roebuck BD; Longnecker DS
Carcinogenesis; 1988 Jun; 9(6):901-6. PubMed ID: 3259478
[TBL] [Abstract][Full Text] [Related]
7. Effect of synthetic protease inhibitor camostate on pancreatic exocrine function in rats.
Otsuki M; Ohki A; Okabayashi Y; Suehiro I; Baba S
Pancreas; 1987; 2(2):164-9. PubMed ID: 3628222
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic effects of cyclosporin A on the exocrine pancreas in rats.
Hirano T; Manabe T; Printz H; Tobe T
Surg Gynecol Obstet; 1992 Dec; 175(6):495-500. PubMed ID: 1280373
[TBL] [Abstract][Full Text] [Related]
9. Effect of a specific serine protease inhibitor on the rat pancreas. II. Influence of camostate on the endocrine pancreas.
Göke B; Siegel EG; Stöckmann F; Lankisch PG; Creutzfeldt W
Digestion; 1985; 31(2-3):128-35. PubMed ID: 3888752
[TBL] [Abstract][Full Text] [Related]
10. Effects of trypsin inhibitor (camostate) on pancreas and CCK release in young and old female rats.
Miyasaka K; Nakamura R; Kitani K
J Gerontol; 1989 Jul; 44(4):M136-40. PubMed ID: 2738309
[TBL] [Abstract][Full Text] [Related]
11. Increased CCK-response to proteinase inhibitor feeding after induction of pancreatic hypertrophy in rats.
Göke B; Fenchel K; Knobloch S; Arnold R; Adler G
Pancreas; 1988; 3(5):576-9. PubMed ID: 3186685
[TBL] [Abstract][Full Text] [Related]
12. [Effect of FOY-305 on the activity and secretion of pancreatic enzymes in vitro].
Stöckmann F; Göke B; Otto J; Lankisch PG; Creutzfeldt W
Z Gastroenterol; 1984 Jun; 22(6):311-7. PubMed ID: 6205521
[TBL] [Abstract][Full Text] [Related]
13. Effects of camostat, a synthetic protease inhibitor, on endocrine and exocrine pancreas of the rat.
Müller MK; Goebell H; Alfen R; Ehlers J; Jäger M; Plümpe H
J Nutr; 1988 May; 118(5):645-50. PubMed ID: 2452864
[TBL] [Abstract][Full Text] [Related]
14. Adaptation of the human pancreas to inhibition of luminal proteolytic activity.
Friess H; Kleeff J; Isenmann R; Malfertheiner P; Büchler MW
Gastroenterology; 1998 Aug; 115(2):388-96. PubMed ID: 9679044
[TBL] [Abstract][Full Text] [Related]
15. Intracellular mechanism responsible for reduced enzyme secretion from camostate-induced hypertrophied pancreas.
Herzig KH; May D; Louie DS; Takahashi T; Göke B; Owyang C
Digestion; 1990; 46 Suppl 2():195-201. PubMed ID: 1702070
[TBL] [Abstract][Full Text] [Related]
16. Endocrine and exocrine pancreatic function after camostate-induced growth of the organ.
von Schönfeld J; Rünzi M; Goebell H; Müller MK
Experientia; 1995 Jun; 51(6):556-60. PubMed ID: 7607295
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of the synthetic trypsin inhibitor camostate in cerulein-induced acute pancreatitis in rats.
Otsuki M; Tani S; Okabayashi Y; Fuji M; Nakamura T; Fujisawa T; Itoh H
Dig Dis Sci; 1990 Feb; 35(2):242-50. PubMed ID: 1689237
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of proteinase inhibitor camostat on exocrine pancreas in fed and fasted rats.
Otsuki M; Tani S; Fujii M; Nakamura T; Okabayashi Y; Koide M
Am J Physiol; 1993 Oct; 265(4 Pt 2):R896-901. PubMed ID: 7694489
[TBL] [Abstract][Full Text] [Related]
19. Chronic oral administration of synthetic trypsin inhibitor camostate reduces amylase release from isolated rat pancreatic acini.
Otsuki M; Fujii M; Nakamura T; Tani S; Okabayashi Y
Int J Pancreatol; 1995 Oct; 18(2):135-43. PubMed ID: 8530829
[TBL] [Abstract][Full Text] [Related]
20. Effects of trypsin inhibitor on the remnant pancreas after 85 percent pancreatectomy in rats.
Baba N; Suzuki T; Tobe T
Jpn J Surg; 1984 Sep; 14(5):420-31. PubMed ID: 6392657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
